Followers | 1078 |
Posts | 80327 |
Boards Moderated | 8 |
Alias Born | 03/10/2009 |
Friday, December 18, 2020 6:59:36 PM
and read here Experience
Landmark Pegasus, Inc.
President
Company Name Landmark Pegasus, Inc.
Dates Employed May 1983 – Present
Employment Duration 37 yrs 8 mos
LocationJupiter, Florida
Founder and President of Landmark Pegasus, Inc., an affiliate of Landmark Financial Corporation, and a seasoned business leader in both the Life Science and Healthcare industries, with extensive experience in corporate strategy, business development, finance and operational management.
Focused initially on development stage life science companies, with a special emphasis on generic drug companies. Among its early clients was Par Pharmaceutical (ENDO), Sidmak Laboratories, Copley Pharmaceutical, Barr Laboratories, Zenith Pharmaceutical — now all part of TEVA.
Retained to restructure and finance Carrington Laboratories and MacroChem Laboratories.
Advised on Copley Pharmaceutical’s restructuring and subsequent private placement of equity and served as a director of the company until the sale of that interest to TA Associates.
Introduced and advised F. Faulding & Co.Ltd., (Australia’s largest pharmaceutical company) on the acquisition of Solvay’s Purepac division.
Gained the trust and respect of our clients and they have experienced greater access to the capital markets which in turn has resulted in higher valuations and greater liquidity for them.
Developed a vast network of both domestic and international industry relationships. Landmark’s clients have included Elan Pharmaceuticals, Fresenius, Ethypharm, Serrano, Altana AG, Dynamit Nobel, and Drug Royalty Corp.
Expanded services to include the Nutrition industry, which today represents a large percentage of the company’s business. Clients include: Nutrition21, Rexall Sundown, Balchem, Glanbia, Twin Labs (LBO) and a 25 year relationship with Pharmachem Laboratories, one of the largest branded ingredient manufacturer’s in the U.S. Medical Foods clients have included Medifast, Inc. (MED) and Pam Labs (Nestle).
Restructuring practice working with many companies like IGI Labs (Teligent – TLGT), Precision Optics, Inc (PEYE), American Bio Medica Corporation (ABMC), and Materials Processing Technology, Inc.
https://www.linkedin.com/in/john-moroney-8417692a/
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent WSCOD News
- Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] • Edgar (US Regulatory) • 03/28/2024 11:50:37 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 09:27:52 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM